Literature DB >> 18427165

Th17 and allergy.

Keisuke Oboki1, Tatsukuni Ohno, Hirohisa Saito, Susumu Nakae.   

Abstract

The identification of novel helper T (Th) cell subsets, i.e., IL-17-producing Th cells (Th17 cells) and regulatory T cells (Treg cells), provided new insight into our understanding of the molecular mechanisms involved in the development of infectious and autoimmune diseases as well as immune responses, and thus led to revision of the classic Th1/Th2 paradigm. Several current lines of evidence from gene-deficient mice indicate that IL-17 and Th17 cells, but not IFN-gamma and Th1 cells, are responsible for the development of autoimmune diseases such as murine arthritis and encephalomyelitis, which have classically been considered to be Th1-mediated disorders. Th17 cells may also contribute to the pathogenesis of classically recognized Th2-mediated allergic disorders. In this review, we summarize the current knowledge regarding IL-17 and Th17 cells and discuss their potential roles in the pathogenesis of allergic disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18427165     DOI: 10.2332/allergolint.R-07-160

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  79 in total

Review 1.  Emerging roles of T helper subsets in the pathogenesis of asthma.

Authors:  Douglas M Durrant; Dennis W Metzger
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

Review 2.  Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.

Authors:  Gyan P Mishra; Viral Tamboli; Jwala Jwala; Ashim K Mitra
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2011-01

3.  Alveolar macrophages stimulate enhanced cytokine production by pulmonary CD4+ T-lymphocytes in an exacerbation of murine chronic asthma.

Authors:  Cristan Herbert; Melissa M Scott; Kim H Scruton; Rylie P Keogh; Kristy C Yuan; Kenneth Hsu; Jessica S Siegle; Nicodemus Tedla; Paul S Foster; Rakesh K Kumar
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

4.  Interleukin-17A increases neurite outgrowth from adult postganglionic sympathetic neurons.

Authors:  Susan P Chisholm; Andrea L Cervi; Simrin Nagpal; Alan E Lomax
Journal:  J Neurosci       Date:  2012-01-25       Impact factor: 6.167

5.  Imbalances of Th17 and Treg cells and their respective cytokines in COPD patients by disease stage.

Authors:  Xiang-Nan Li; Xue Pan; Dong Qiu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

6.  CXCR4 inhibitor attenuates ovalbumin-induced airway inflammation and hyperresponsiveness by inhibiting Th17 and Tc17 cell immune response.

Authors:  Huilong Chen; Xiangqin Xu; Jieming Teng; Sheng Cheng; Hansvin Bunjhoo; Yong Cao; Jin Liu; Jungang Xie; Congyi Wang; Yongjian Xu; Weining Xiong
Journal:  Exp Ther Med       Date:  2016-03-10       Impact factor: 2.447

7.  A generally applicable translational strategy identifies S100A4 as a candidate gene in allergy.

Authors:  Sören Bruhn; Yu Fang; Fredrik Barrenäs; Mika Gustafsson; Huan Zhang; Aelita Konstantinell; Andrea Krönke; Birte Sönnichsen; Anne Bresnick; Natalya Dulyaninova; Hui Wang; Yelin Zhao; Jörg Klingelhöfer; Noona Ambartsumian; Mette K Beck; Colm Nestor; Elsa Bona; Zou Xiang; Mikael Benson
Journal:  Sci Transl Med       Date:  2014-01-08       Impact factor: 17.956

8.  FOXP3(+)Treg/Th17 cell imbalance in lung tissues of mice with asthma.

Authors:  Hua Jiang; Xianbo Wu; Haiyan Zhu; Yiqiang Xie; Songqi Tang; Yuji Jiang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

9.  Heme oxygenase-1 exerts a protective role in ovalbumin-induced neutrophilic airway inflammation by inhibiting Th17 cell-mediated immune response.

Authors:  Yanjie Zhang; Liya Zhang; Jinhong Wu; Caixia Di; Zhenwei Xia
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

Review 10.  Hypersensitivity to titanium: a less explored area of research.

Authors:  Vasantha Vijayaraghavan; Ajay V Sabane; K Tejas
Journal:  J Indian Prosthodont Soc       Date:  2012-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.